Piper Sandler Upgrades Guardant Health to Overweight, Announces $40 Price Target
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg has upgraded Guardant Health (NASDAQ:GH) from Neutral to Overweight and announced a $40 price target.
September 27, 2023 | 11:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guardant Health's stock has been upgraded by Piper Sandler from Neutral to Overweight, with a new price target of $40.
The upgrade from Piper Sandler is a positive signal for Guardant Health. It indicates that the analyst believes the company's stock will outperform the market or its sector in the near term. The new price target of $40 also suggests that the analyst sees significant upside potential for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100